RIDGEBACK BIOTHERAPEUTICS

Founded in 2016, Ridgeback Biotherapeutics is a biotech company focused on developing transformational therapies to resolve or mitigate the effects of emerging infectious diseases... Ridgeback is committed, proud, and humbled to work at the unique intersection of cutting-edge science, collaborative academic-government-private sector research and development, and public health response and preparedness... At Ridgeback, we commit resources and expertise for undefined and poorly understood diseases early in the pharmaceutical development cycle, at a time generally when few stakeholders are prepared to make the necessary commitments.

Also known as: Ridgeback

Primary location: Miami United States